Retention samples [Regulatives / Guidelines]

posted by dshah – India/United Kingdom, 2021-04-13 19:07 (285 d 18:18 ago) – Posting: # 22308
Views: 1,572

(edited by dshah on 2021-04-13 19:19)

Dear Vinodvasala!

Please search in forum for previous discussions  ,  ,  . In general as per Compliance Policy for the Quantity of Bioavailability and Bioequivalence Samples Retained Under 21 CFR 320.38(c)- 30 units for Drug Products Manufactured in Single-Dose Units or 3 units for Drug Products Manufactured in Multi-Dose Units for US regulatory and 300 units for 5X testing (safer approach).
Regards,
Dshah

Complete thread:

Activity
 Admin contact
21,849 posts in 4,572 threads, 1,555 registered users;
online 7 (1 registered, 6 guests [including 4 identified bots]).
Forum time: Monday 12:26 CET (Europe/Vienna)

Do, or do not.
There is no ‘try’.    Yoda

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5